Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.
- NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_assertion description "[Our findings suggest that promoter hypermethylation of RASSF1A and HIC1 genes play a role in resistance of GCT, while the transcriptional inactivation of MGMT by epigenetic alterations confer exquisite sensitivity to cisplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.
- NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_assertion evidence source_evidence_literature NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.
- NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_assertion SIO_000772 15149548 NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.
- NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_assertion wasDerivedFrom befree-20140225 NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.
- NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_assertion wasGeneratedBy ECO_0000203 NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.
- befree-20140225 importedOn "2014-02-25" NP758046.RAnNx90bAW3MbjgooeFSDKpltH0sf1zQk4iG_XqSTlb4E130_provenance.